These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7431647)

  • 41. [Laboratory diagnosis of left atrial thrombi in patients with mitral stenosis].
    Hayashi I; Miyauchi T; Sakamoto K; Sanada J; Nakamura K; Arima T; Otsuji S; Taira A
    J Cardiol; 1993; 23(2):177-83. PubMed ID: 8176629
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Blood coagulation and fibrinolytic studies in patients with toxemia of pregnancy].
    Okamiya H
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Nov; 42(11):1557-64. PubMed ID: 2273312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of atrial fibrillation on coagulo-fibrinolytic markers in patients with cerebral infarction.
    Ono N; Koyama T; Suehiro A; Oku K; Fujikake K; Kakishita E
    Int Angiol; 1992; 11(4):298-303. PubMed ID: 1284251
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A coagulation of fibrinolytic study in children with nephrotic syndrome: evaluation of hypercoagulability by measuring with plasmin- alpha 2 plasmin inhibitor complex and FDP D-dimer].
    Oikawa T; Muramatsu Y; Akashi S; Usui N
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):144-9. PubMed ID: 9134831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Laboratory diagnosis of left atrial thrombi in patients with mitral stenosis].
    Hayashi I
    Fukuoka Igaku Zasshi; 1991 Nov; 82(11):550-61. PubMed ID: 1774012
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery.
    Kongsgaard UE; Smith-Erichsen N; Geiran O; Bjørnskau L
    Thorac Cardiovasc Surg; 1989 Jun; 37(3):158-62. PubMed ID: 2527423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hypercoagulability in atrial fibrillation and its relationship with risk factors for systemic embolism].
    Pérez LA; Corbalán R; Acevedo M; Pereira J; Braun S; Tapia J; Kramer A; Lira MT; Huete I; Sepúlveda G; Springmüller D
    Rev Med Chil; 2002 Oct; 130(10):1087-94. PubMed ID: 12491825
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.
    Kario K; Matsuo T
    Atherosclerosis; 1993 Nov; 103(2):131-8. PubMed ID: 8292090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Left atrial platelet activity with rheumatic mitral stenosis: correlation study of severity and platelet P-selectin expression by flow cytometry.
    Chen MC; Wu CJ; Yip HK; Chang HW; Fang CY; Yu TH; Fu M
    Chest; 2003 Nov; 124(5):1663-9. PubMed ID: 14605032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study.
    Goldsmith I; Kumar P; Carter P; Blann AD; Patel RL; Lip GY
    Am Heart J; 2000 Nov; 140(5):777-84. PubMed ID: 11054625
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)].
    Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E
    Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
    Vaziri ND; Gonzales EC; Wang J; Said S
    Am J Kidney Dis; 1994 Jun; 23(6):828-35. PubMed ID: 8203365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fibrinopeptide A (FPA) levels in atrial fibrillation and the effects of heparin administration.
    Uno M; Tsuji H; Sawada S; Toyoda T; Nakagawa M
    Jpn Circ J; 1988 Jan; 52(1):9-12. PubMed ID: 3361696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Haematological abnormalities in rheumatic mitral valve disease.
    Knight CJ
    Int J Cardiol; 2000 Feb; 72(3):207-8. PubMed ID: 10716127
    [No Abstract]   [Full Text] [Related]  

  • 55. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of transcatheter hepatic arterial embolization on coagulation and fibrinolysis in patients with hepatocellular carcinoma.
    Sakon M; Kambayashi J; Taniguchi K; Yoshida T; Shiba E; Kawasaki T; Tsuji Y; Yukawa M; Murata K; Gotoh M
    Am J Gastroenterol; 1991 Dec; 86(12):1800-3. PubMed ID: 1660219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Coagulation and fibrinolysis in pregnancy].
    Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
    Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.
    Li-Saw-Hee FL; Blann AD; Goldsmith I; Lip GY
    Am J Cardiol; 1999 Apr; 83(8):1206-9. PubMed ID: 10215285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical significance of plasma alpha 2-plasmin inhibitor activity in obstetrics].
    Miura Y
    Nihon Ika Daigaku Zasshi; 1986 Jun; 53(3):258-70. PubMed ID: 3734048
    [No Abstract]   [Full Text] [Related]  

  • 60. Double giant thrombi in the left atrium in a patient with rheumatic mitral valve stenosis and atrial fibrillation.
    Akcay M; Gulel O; Bahcivan M; Yuksel S
    Eur J Cardiothorac Surg; 2013 Dec; 44(6):1150. PubMed ID: 23671200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.